Heart Disease News and Research

Latest Heart Disease News and Research

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.

2 Sep 2010

Henry Schein to deliver health care supplies to victims of devastating floods in Pakistan

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, is working with its non-governmental organization partners – Direct Relief, International Medical Corps, Americares, and Heart to Heart – to deliver essential health care supplies to victims of the devastating floods in Pakistan, which left more than a thousand dead, an estimated four million homeless, and more than 15 million people affected.

31 Aug 2010

Royal Caribbean encourages consumers to use their hard-earned vacation days

Over-worked, over-tired and stressed-out workers have one more thing to worry about this coming Labor Day – how many vacation days they could potentially be losing this year. And if The President of the United States, who just returned from a respite on Martha's Vineyard, can still find time, then shouldn't everyone?

31 Aug 2010

Incidence of acute myocardial infarction increases among young Italian women: Study

The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation, a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy. The results were published in Aging Clinical Experimental Research.

31 Aug 2010

ESC issues revised practice guidelines for management of AF

The European Society of Cardiology today issued revised practice guidelines for the management of atrial fibrillation, including guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

31 Aug 2010

Study on conflict between capacity to pay and need for health care

Cardiovascular disease (CVD) in all its forms is the biggest cause of death across Europe. Although there is little doubt that better focus on prevention can lessen its impact, we are left with a series of fundamental questions to what extent can the impact be reduced, and at what cost. And are the health benefits of prevention worth the investment. The EUROASPIRE III health economics study aims to find out.

31 Aug 2010

Recommendations for revascularisation in coronary artery disease patients

There have been several studies into the impact of completeness of revascularisation in recent years, yet few clear recommendations are available on the likely clinical outcomes. This topic is not formally addressed in either the European Society of Cardiology guidelines or those jointly issued by the American Heart Association and American College of Cardiology.

31 Aug 2010

DANPACE trial shows dual chamber pacing decreases atrial fibrillation in sick sinus syndrome

DANPACE, a Danish multicentre randomised trial comparing single lead atrial and dual chamber pacing in patients with sick sinus syndrome, concludes that dual chamber pacing, which was associated with lower rates of atrial fibrillation and re-operation, "should be the preferred pacing mode".

31 Aug 2010

Standard dose of UFH optimal for treatment of PCI patients on fondaparinux: Study

A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux.

31 Aug 2010

Scientists find effective training regimens to determine exercise intensity

For competitive bicyclists with goals - whether competing in the Tour de France or aiming for the podium at a local race - faster cycling comes from training regimens based on various zones of exercise intensity. New research from exercise scientists at the University of New Hampshire has found that effective training regimens, which generally are created after expensive, time-consuming laboratory tests, can be developed from a relatively simple, do-it-yourself test.

31 Aug 2010

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".

31 Aug 2010

New book explores history, benefits of tomato

A new history of the tomato in Italy by a University of Leicester historian throws some surprising insights on an item of food that we have been accustomed to think of as intrinsically Italian.

31 Aug 2010

Nutritional recommendations for management of sarcopenia published

Nutritional recommendations for the management of sarcopenia -- also described as age-related muscle and functional loss -- were published this past week in the clinical publication, Journal of American Medical Directors Association.

31 Aug 2010

Outpatient prevention programme by nurses reduces risk of recurrent complications in heart patients

A six-month outpatient prevention programme conducted by nurses has resulted in significant and sustained improvements in the control of cardiovascular risk factors, including high cholesterol or high blood pressure, in patients hospitalised for a heart attack or impending heart attack.

31 Aug 2010

ECG-based screening for young footballers at risk of heart disease needs to be reviewed: Study

The screening process for young footballers at risk of heart disease needs to be re-evaluated. That is the conclusion of a recent study, which has shown that the common criteria used for assessment does not take into account the type and intensity of the exercise performed. The single most common cause of sudden death in competitive footballers is hypertrophic cardiomyopathy - a disease that thickens the heart muscle without any obvious cause.

31 Aug 2010

International Symposium to explore Hybrid approach for congenital heart disease

Interventional cardiologists and cardiothoracic surgeons throughout the United States and the world, who treat patients with congenital heart disease, will gather at the Hilton Columbus at Easton Town Center August 31-September 2, 2010 for the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).

31 Aug 2010

Study determines dose-specific patterns associated with generic statin switching

Research conducted in the Netherlands has highlighted the need for care when switching patients under treatment for high cholesterol from branded to generic drug families. The study shows that much of the switching can result in patients inadvertently receiving non-equivalent doses, potentially leading to an increased risk of downstream heart disease and stroke.

31 Aug 2010

Veterans with PTSD at greater risk for dementia

Results of a study reported in the September issue of the Journal of the American Geriatrics Society suggest that Veterans with post-traumatic stress disorder (PTSD) have a greater risk for dementia than Veterans without PTSD, even those who suffered traumatic injuries during combat.

31 Aug 2010

Phase 3 AVERROES trial reveals apixaban effective for atrial fibrillation patients unsuitable for warfarin

The phase 3 AVERROES (Apixaban Versus Acetylsalicylic acid (ASA) to Prevent Strokes) trial, designed to show the superiority of apixaban over aspirin for the prevention of stroke or systemic embolism in high-risk atrial fibrillation patients unsuitable for treatment with a vitamin K antagonist (warfarin), was terminated early following a recommendation from the Data Monitoring Committee.

31 Aug 2010

Social interaction reduces physical damage to brain by heart attack: Research

A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.

31 Aug 2010

Heart Disease News and Research

Latest Heart Disease News and Research

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

Henry Schein to deliver health care supplies to victims of devastating floods in Pakistan

Royal Caribbean encourages consumers to use their hard-earned vacation days

Incidence of acute myocardial infarction increases among young Italian women: Study

ESC issues revised practice guidelines for management of AF

Study on conflict between capacity to pay and need for health care

Recommendations for revascularisation in coronary artery disease patients

DANPACE trial shows dual chamber pacing decreases atrial fibrillation in sick sinus syndrome

Standard dose of UFH optimal for treatment of PCI patients on fondaparinux: Study

Scientists find effective training regimens to determine exercise intensity

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

New book explores history, benefits of tomato

Nutritional recommendations for management of sarcopenia published

Outpatient prevention programme by nurses reduces risk of recurrent complications in heart patients

ECG-based screening for young footballers at risk of heart disease needs to be reviewed: Study

International Symposium to explore Hybrid approach for congenital heart disease

Study determines dose-specific patterns associated with generic statin switching

Veterans with PTSD at greater risk for dementia

Phase 3 AVERROES trial reveals apixaban effective for atrial fibrillation patients unsuitable for warfarin

Social interaction reduces physical damage to brain by heart attack: Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Heart Disease News and Research

Latest Heart Disease News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in